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Abstract
Takayasu’s arteritis (TA) is a rare inflammatory disease of
the arteries that affects women of childbearing age. The opti-
mal management for pregnant patients with this disease has
not yet been defined. The course of disease seems to be
neither affected nor worsened by pregnancy. We could not
find reported maternal deaths directly related to pregnancy.
However, many authors report maternal as well as fetal unfa-
vorable events in the course of pregnancy. We describe a 25-
year-old primigravida of Turkish-Greek origin who presented
at 30 weeks of pregnancy with active TA. In the 37th week,
intrauterine fetal death occurred. Our patient did not show
high blood pressure or aortic inflammation. The course of
her disease was stable. Whether a newly diagnosed TA
during pregnancy should be regarded as an indication for
premature delivery is discussed. An interdisciplinary collab-
oration of rheumatologists, nephrologists and obstetricians is
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Introduction
Takayasu’s arteritis (TA) is an inflammatory disease of the
arteries that affects women of childbearing age. It is a rare
chronic vasculitis of unknown etiology, firstly described in
1908 by the Japanese ophthalmologist Mikito Takayasu. It
has variable geographical distribution with the greatest prev-
alence in Asians, especially Japan, and the Orient. Women
are affected in 80–90% of cases with a mean age of pres-
entation in the second and third decade of life, reflected in
a synonym for TA as ‘‘young female arteritis’’. It is not
uncommon to encounter this disease during pregnancy.
Optimal management for pregnant patients with this dis-
ease has not yet been established. Due to the manifold car-
diovascular complications that can occur in the course of
the disease, management of pregnancies in TA patients is a
challenge for the obstetrician, the rheumatologist and the
cardiologist.
Four questions have not been fully answered yet:
• How to control a pregnancy in a TA patient? When is the
optimal time for delivery and which is the best mode of
delivery?
• Does the status of the disease improve, unchange, or
worsen during pregnancy?
• How does a pregnancy affect the long-term prognosis of
TA patients?
• How to achieve a good fetal outcome?
Guidelines for the treatment of pregnant women with TA
are necessary. There are only few case reports in the literature
about women who were diagnosed with TA during pregnan-
cy. Since this is a rare, but not totally uncommon event, it
might also be necessary to suggest guidelines for the treat-
ment of these patients.
Case report
We describe a 25-year-old primigravida of Turkish-Greek
origin who presented at 30 weeks of pregnancy with strong
right-sided neck pain. The pain had been present together
with numbness in the right half of her face since two days
prior to first presentation. The painful feelings was also elic-
ited by stretching her right arm. During the next days, the
patient showed a right-sided facial paresis. On the right arm,
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Figure 2 Native MRI of neck (2 levels) shows that the right ver-
tebral artery is closed (arrowhead) and a wall thickening of the left
common carotid artery (arrow). No hints for fresh bleeding or older
vascular lesions can be seen.
Figure 1 Native MRI of head (3 levels) shows a closure of the
right vertebral artery.
a pulse could not be found. Pulses in all other areas were
normal, heart auscultation revealed no abnormalities. Bruits
over the right and left carotid were audible, louder on the
right side. Blood pressure was 110/70 mm Hg measured on
the left arm, but could not be measured on the right arm.
The patient had no fever. The neurological examination was
normal.
Laboratory values showed a slightly elevated C-reactive
protein (16 mg/L) and leukocyte count (11.12 G/L). Creati-
nine was 0.4 mg/dL, alkaline phosphatase 143 U/L, GOT
36 U/L, fibrinogen 511 mg/dL, d-dimers 222 mg/L, hemo-
globin 11.1 g/dL, hematocrit 33.4%, thyrotropin 27.27
uIU/mL. All other values were normal.
Doppler scan of the head arteries showed a long vessel
wall thickening of both common carotid arteries with ste-
nosis of 50–60% up to the bifurcation. The intima-media-
complex was 1.4 mm in the left arteria carotis communis
(ACC) and 1.2 mm in the right ACC. The arteria carotis
interna (ACI) and arteria carotis externa (ACE) on both sides
were free. A complete closure of the right vertebral artery
and high-grade stenosis of the right subclavian artery were
also diagnosed. Doppler scan of the extremities showed a
systolic pressure difference of 20 mm Hg between the right
(70 mm Hg) and the left brachial artery (90 mm Hg).
Native MRI of head (3 levels) and neck (2 levels) showed
closure of the right vertebral artery and wall thickening of
the left common carotid artery. No hints for fresh bleeding
or older vascular lesions were seen (Figures 1 and 2).
A diagnosis of TA was made. Besides, the patient had a
congested right kidney with urinary tract infection that was
successfully treated with antibiotics, Hashimoto thyroiditis
treated with euthyrox (Levothyroxin, Merck kGaA, Darm-
stadt, Germany) 100 mg and mild gestational diabetes. Blood
sugar values could be controlled by dietary measures.
Immunosuppressive therapy with high dose cortisone
(methyl prednisolone 40 mg/d) was started. Neck pain and
facial paresis disappeared completely. Numbness in the right
half of face and right arm was still present, but decreased
gradually. The arterial alterations described and the serologic
parameters remained stable over two months, possibly not
indicating an ‘‘active’’ onset phase, but rather a ‘‘burn-out’’
phase of TA. The pregnancy was controlled tightly in our
clinic. Its course was uneventful except for a small for ges-
tational age fetus, growing steadily on the fifth percentile.
The ultrasound examination at 35q1 weeks’ gestation
showed a 2027 g estimated weight. Doppler of the umbilical
artery showed a resistance index (RI) of 0.63 with a positive
end diastolic flow (EDF). The Doppler of maternal vessels
showed a RI of 0.49 and a pulsatility index (PI) of 1.27 in
the left uterine artery and a RI of 0.51/PI of 1.28 in the right
uterine artery. In an interdisciplinary case conference, it was
decided that no indication for premature delivery existed.
Instead, induction of labor at 37q0 weeks of gestation was
recommended. We also recommended seeing her gynecolo-
gist for weekly cardiotocography and Doppler studies, but
we do not know whether she was compliant. Contraction
stress tests were not performed.
The patient was examined twice in our clinic (level one
center for perinatal medicine): at initial presentation after TA
had been diagnosed, and in 36q6 weeks of gestation, the
day before induction of labor was scheduled. On a routine
sonography on her second admission, we diagnosed intrau-
terine fetal death. After induction of labor, the patient deliv-
ered a dead male fetus with the umbilical cord wrapped twice
around the neck (weight 2050 g, length 47 cm). Pathology
showed a growth restricted male fetus without internal or
external malformation. Histological work-up of the placenta
did not show manifestation of TA.
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Tables 1 and 2 describe all reviews published on TA in
pregnancy in the literature from 1980 to 2007 searching
the PubMed Database (http://www.ncbi.nlm.nih.gov/sites/
entrez). A literature search also revealed several well-docu-
mented case reports about TA patients in pregnancy (Table
4).
TA is a rare, chronic, giant-cell vasculitis which primarily
involves the aorta, its main branches and coronary and pul-
monary arteries. The disease causes various clinical condi-
tions such as arm claudication, decreased artery pulses,
carotodynia, visual loss, stroke, aortic regurgitation, hyper-
tension and congestive heart failure. Clinical presentation
may be insidious and diagnosis is often delayed. Table 3
shows the criteria for active disease according to Kerr w18x.
In 1990, the American College of Rheumatology proposed
six diagnostic criteria, at least three of them are required for
classifying a patient as having TA (Table 4). Ishikawa clas-
sified TA patients according to the presence of complications
at the time of first diagnosis and thus identified individual
prognostic markers w15x. The natural course of TA is chronic
and progressive, with a reported survival range of 1–15
years.
The etiology of TA is still unknown. The inflammatory
lesions in TA originate in the vasa vasorum and are followed
by cellular infiltration of the outer layer of the media and/or
adventitia. So far, the antigen(s) that trigger(s) the autoim-
mune process could not be identified w23x. As far as we
know, autoantibodies known to play a role in the pathogen-
esis of other vascular diseases – like ANCA antibodies in
Wegener’s granulomatosis – do not contribute to the devel-
opment of TA. Possibly, antiendothelial autoantibodies are
involved w23x. However, no laboratory tests for autoantibod-
ies have been developed to date for the diagnosis of TA. The
inflammatory reaction in TA responds to glucocorticoids
which are the drugs of first choice in pregnancy w10x. If
prednisone treatment fails, azathioprine should be consid-
ered. Hypertension should be treated very agressively with
alpha-methyldopa, calcium channel blockers or hydralazine.
Pregnancy occurs more frequently in patients with TA than
in patients with other forms of vasculitis. We could identify
137 cases of pregnant patients with TA in the literature. Fer-
tility and the incidence of miscarriages are presumably unaf-
fected by TA. A total of 12.4% of the pregnancies terminated
with abortion, a third of those artificially because maternal
hypertension could not be sufficiently controlled. In the stud-
ies we identified, no cases of direct maternal death related
to pregnancy have been reported. However, many of the
reports listed above describe unfavorable events: 30.6% suf-
fered from uncontrolled and/or exacerbating hypertension,
with superimposed preeclampsia being the most common
(described in 19.7% of cases), followed by congestive heart
failure (3.9% of cases). Progression of renal insufficiency,
intra- and antepartum hemorrhage, myocardial infarction, ret-
inopathy, aortic regurgitation, aortic aneurysms and pulmo-
nary embolism have also been reported in pregnant TA
Hauenstein et al., Takayasu’s arteritis in pregnancy 59







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































60 Hauenstein et al., Takayasu’s arteritis in pregnancy



































































































































































































































































































































































































































































































































































































































































































































































































Hauenstein et al., Takayasu’s arteritis in pregnancy 61
Article in press - uncorrected proof
Table 3 Criteria for active disease (Kerr 1994).
• Features of vascular ischemia or inflammation (such as
vascular pain (carotodynia), claudication, diminished or
absent pulse, bruit), asymmetric blood pressure in either
upper or lower limbs (or both)
• Elevated ESR
• Systemic features, such as fever, musculoskeletal (without any
other cause identified)
• Typical angiographic features
• New onset or worsening of two or more features indicates
‘‘active disease’’
Criteria for remission
• Complete resolution or stabilization of all clinical features
• Fixed vascular lesions
Table 4 1990 ACR criteria for the classification of Takayasu’s arteritis (Arend et al. 1999).
Criteria Definition
Age at disease onset in years Development of symptoms or findings related to Takayasu arteritis
at age -40 years
Claudication of extremities Development and worsening of fatigue and discomfort in muscles of
one or more extremity while in use, especially the upper extremities
Decreased brachial artery pulse Decreased pulsation of one or both brachial arteries
BP difference )10 mm Hg Difference of )10 mm Hg in systolic blood pressure between arms
Bruit over subcavian arteries or aorta Bruit audible on auscultation over one or both subclavian arteries or
abdominal aorta
Arteriogram abnormality Arteriographic narrowing or occlusion of the entire aorta, its primary
branches, or large arteries in the proximal upper or lower extremities,
not due arteriosclerosis, fibro-muscular dysplasia, or similar causes:
changes usually focal or segmental
patients. Most of those unfavorable events occur in the peri-
natal period.
The course of disease seems to be unaffected or worsened
by pregnancy w16, 21, 26x. However, it is yet unclear whether
pregnancies affect the individual prognosis. So far, suitable
criteria to predict the final maternal and fetal outcomes have
not been developed. Many case reports show that even
patients with multiple stenoses in major arteries have a
chance of delivering a mature, normal baby. In 83.9% of the
cases that we reviewed ended with delivery of a healthy
child. In patients who were diagnosed as TA during preg-
nancy, the course of disease does not seem to be more
aggressive from other TA patients. Induction of labor or
cesarean section are not indicated for all pregnant TA
patients w3x. In the 137 cases we reviewed, 40.8% of patients
had a spontaneous vaginal delivery with good maternal and
fetal outcome. Vaginal delivery at term has been recom-
mended in a recent publication w24x. However, the fact that
systolic blood pressure rises significantly during the second
stage of labor should be considered w27x. A total of 9.7% of
patients in the cases reviewed had a forceps or vacuum deliv-
ery, in most instances performed in order to shorten the sec-
ond stage of labor and as many as 37.6% of patients were
delivered by cesarean section. Regarding the influence of TA
on the fetus, intrauterine growth restriction has been reported
in 19.7% of cases, most probably due to decreased uterine
perfusion as a consequence of arterial disease w20, 26x. Six
intrauterine fetal deaths have also been reported, representing
8.2% of cases w11, 27x.
Our patient fulfilled all ACR criteria for the diagnosis of
TA: she was under 40 years of age, felt fatigue and muscle
discomfort in the right arm, showed a systolic pressure dif-
ference of 20 mm Hg between arms, pulse of the right bra-
chial artery could not be felt, bruit was audible over both
carotid arteries, and the MRI examination showed vessel
abnormalities. However, she did not fulfill any of the criteria
defined by Sharma et al. w27x indicating a bad prognosis for
pregnancy. Our patient did not have high blood pressure or
aortal inflammation. The course of her disease was stable,
and the pregnancy uneventful. Placental histology did not
show any manifestations of TA. However, we do not regard
the fetal death merely as an unfortunate coincidence with
TA. Other mechanisms – like vascular damage on the mater-
nal side restricting fetal nutrition but not manifesting itself
in placental histology – could have played a role. It is hard
to believe that the onset of a severe vascular disease in the
middle of pregnancy has not contributed to the outcome. At
the very least, the diagnosis of TA should have led to tighter
surveillance of the pregnancy. As we want to show by report-
ing our case, management of such pregnancies – even though
our patient suffered no major complications of TA – should
not be taken lightly. Tight cardiotocography and ultrasound
control should be scheduled. Possibly, fetal death could have
been avoided in our case had the patient been hospitalized
or controlled at least twice weekly in a level I center for
perinatal medicine. Regarding the unfavorable outcome, it
should be discussed if a newly diagnosed TA during preg-
nancy should not by itself be regarded as an indication for
elective premature delivery. An interdisciplinary collabora-
tion of rheumatologists, nephrologists and obstetricians is
necessary to improve maternal and fetal outcome.
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